دنبال کردن
J. Joshua Smith, M.D., Ph.D., F.A.C.S.
J. Joshua Smith, M.D., Ph.D., F.A.C.S.
Memorial Sloan Kettering Cancer Center | Colorectal Service | Dept of Surgery | Assoc. Member
ایمیل تأیید شده در mskcc.org - صفحهٔ اصلی
عنوان
نقل شده توسط
نقل شده توسط
سال
Nomograms in oncology: more than meets the eye‏
VP Balachandran, M Gonen, JJ Smith, RP DeMatteo‏
The lancet oncology 16 (4), e173-e180, 2015‏
27622015
PD-1 blockade in mismatch repair–deficient, locally advanced rectal cancer‏
A Cercek, M Lumish, J Sinopoli, J Weiss, J Shia, M Lamendola-Essel, ...‏
New England Journal of Medicine 386 (25), 2363-2376, 2022‏
11412022
Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer‏
JJ Smith, NG Deane, F Wu, NB Merchant, B Zhang, A Jiang, P Lu, ...‏
Gastroenterology 138 (3), 958-968, 2010‏
7242010
Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy‏
J Garcia-Aguilar, S Patil, MJ Gollub, JK Kim, JB Yuval, HM Thompson, ...‏
Journal of Clinical Oncology 40 (23), 2546-2556, 2022‏
6132022
Adoption of total neoadjuvant therapy for locally advanced rectal cancer‏
A Cercek, CSD Roxburgh, P Strombom, JJ Smith, LKF Temple, GM Nash, ...‏
JAMA oncology 4 (6), e180071-e180071, 2018‏
5792018
Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy‏
JJ Smith, P Strombom, OS Chow, CS Roxburgh, P Lynn, A Eaton, ...‏
JAMA oncology 5 (4), e185896-e185896, 2019‏
5222019
A rectal cancer organoid platform to study individual responses to chemoradiation‏
K Ganesh, C Wu, KP O’Rourke, BC Szeglin, Y Zheng, CEG Sauvé, ...‏
Nature medicine 25 (10), 1607-1614, 2019‏
4472019
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer …‏
JJ Smith, OS Chow, MJ Gollub, GM Nash, LK Temple, MR Weiser, ...‏
BMC cancer 15, 1-13, 2015‏
3752015
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors‏
C Valero, M Lee, D Hoen, K Weiss, DW Kelly, PS Adusumilli, PK Paik, ...‏
Nature communications 12 (1), 729, 2021‏
3282021
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance‏
JM Balko, RS Cook, DB Vaught, MG Kuba, TW Miller, NE Bhola, ...‏
Nature medicine 18 (7), 1052-1059, 2012‏
3232012
Association of preoperative and postoperative serum carcinoembryonic antigen and colon cancer outcome‏
T Konishi, Y Shimada, M Hsu, L Tufts, R Jimenez-Rodriguez, A Cercek, ...‏
JAMA oncology 4 (3), 309-315, 2018‏
2662018
Advances and challenges in treatment of locally advanced rectal cancer‏
JJ Smith, J Garcia-Aguilar‏
Journal of clinical oncology 33 (16), 1797-1808, 2015‏
2212015
The association between tumor mutational burden and prognosis is dependent on treatment context‏
C Valero, M Lee, D Hoen, J Wang, Z Nadeem, N Patel, MA Postow, ...‏
Nature genetics 53 (1), 11-15, 2021‏
2152021
Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin‏
TJ Freeman, JJ Smith, X Chen, MK Washington, JT Roland, AL Means, ...‏
Gastroenterology 142 (3), 562-571. e2, 2012‏
2092012
Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma‏
CW Barrett, W Ning, X Chen, JJ Smith, MK Washington, KE Hill, ...‏
Cancer research 73 (3), 1245-1255, 2013‏
2062013
Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma‏
LH Lee, MS Cavalcanti, NH Segal, JF Hechtman, MR Weiser, JJ Smith, ...‏
Modern Pathology 29 (11), 1433-1442, 2016‏
1972016
Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells‏
AB Singh, A Sharma, JJ Smith, M Krishnan, X Chen, S Eschrich, ...‏
Gastroenterology 141 (6), 2140-2153, 2011‏
1872011
Mismatch repair–deficient rectal cancer and resistance to neoadjuvant chemotherapy‏
A Cercek, G Dos Santos Fernandes, CS Roxburgh, K Ganesh, S Ng, ...‏
Clinical Cancer Research 26 (13), 3271-3279, 2020‏
1852020
Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation‏
P Dhawan, R Ahmad, R Chaturvedi, JJ Smith, R Midha, MK Mittal, ...‏
Oncogene 30 (29), 3234-3247, 2011‏
1852011
International consensus recommendations on key outcome measures for organ preservation after (chemo) radiotherapy in patients with rectal cancer‏
E Fokas, A Appelt, R Glynne-Jones, G Beets, R Perez, J Garcia-Aguilar, ...‏
Nature Reviews Clinical Oncology 18 (12), 805-816, 2021‏
1752021
سیستم در حال حاضر قادر به انجام عملکرد نیست. بعداً دوباره امتحان کنید.
مقاله‌ها 1–20